890 related articles for article (PubMed ID: 28862397)
1. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
[TBL] [Abstract][Full Text] [Related]
2. Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry.
Zurkova M; Kriegova E; Kolek V; Lostakova V; Sterclova M; Bartos V; Doubkova M; Binkova I; Svoboda M; Strenkova J; Janotova M; Plackova M; Lacina L; Rihak V; Petrik F; Lisa P; Bittenglova R; Tyl R; Ondrejka G; Suldova H; Lnenicka J; Psikalova J; Snizek T; Homolka J; Kralova R; Kervitzer J; Vasakova M; ;
Respir Res; 2019 Jan; 20(1):16. PubMed ID: 30665416
[TBL] [Abstract][Full Text] [Related]
3. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
[TBL] [Abstract][Full Text] [Related]
4. Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.
Kondoh Y; Taniguchi H; Ogura T; Johkoh T; Fujimoto K; Sumikawa H; Kataoka K; Baba T; Colby TV; Kitaichi M
Respirology; 2013 Jul; 18(5):820-6. PubMed ID: 23489318
[TBL] [Abstract][Full Text] [Related]
5. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
[TBL] [Abstract][Full Text] [Related]
6. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
7. Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients.
Beltramo G; Thabut G; Peron N; Nicaise P; Cazes A; Debray MP; Joannes A; Castier Y; Mailleux AA; Frija J; Pradère P; Justet A; Borie R; Dombret MC; Taille C; Aubier M; Crestani B
Respir Med; 2018 Feb; 135():15-21. PubMed ID: 29414448
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
9. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
[TBL] [Abstract][Full Text] [Related]
10. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
Bodlet A; Maury G; Jamart J; Dahlqvist C
Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
[TBL] [Abstract][Full Text] [Related]
11. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Callahan SJ; Xia M; Murray S; Flaherty KR
Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
[TBL] [Abstract][Full Text] [Related]
13. Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores.
Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Egashira R; Brun AL; Nair A; Walsh SLF; Karwoski R; Wells AU
Eur Radiol; 2018 Mar; 28(3):1318-1327. PubMed ID: 28963678
[TBL] [Abstract][Full Text] [Related]
14. The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry.
Štefániková M; Doubková M; Ovesná P; Šterclová M; Lacina L; Žurková M; Plačková M; Bartoš V; Janíčková I; Bittenglová R; Anton J; Sýkorová Ľ; Lošťáková V; Musilová P; Šuldová H; Mokošová R; Didyk J; Šišáková L; Lisá P; Lněnička J; Dařičková H; Doležel D; Pšikalová J; Tyl R; Králová R; Vašáková MK
BMC Pulm Med; 2023 May; 23(1):154. PubMed ID: 37138274
[TBL] [Abstract][Full Text] [Related]
15. Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality.
Loeh B; Brylski LT; von der Beck D; Seeger W; Krauss E; Bonniaud P; Crestani B; Vancheri C; Wells AU; Markart P; Breithecker A; Guenther A
Chest; 2019 May; 155(5):972-981. PubMed ID: 30742809
[TBL] [Abstract][Full Text] [Related]
16. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
[TBL] [Abstract][Full Text] [Related]
17. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis.
Yoon HY; Kim TH; Seo JB; Lee SM; Lim S; Lee HN; Kim N; Han M; Kim DS; Song JW
Respirology; 2019 Jan; 24(1):55-62. PubMed ID: 30136753
[TBL] [Abstract][Full Text] [Related]
18. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.
Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Lee YC; Kirchgaessler KU; Bartley K; Bondue B
Respir Res; 2019 Oct; 20(1):231. PubMed ID: 31651324
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
